Attention-Deficit-Disordered Children — Digital Media Usage With Impulsivity and Attention Deficit in Children
Citation(s)
Abidin, R R. (1995). Parenting Stress Index (PSI) manual . Odessa, FL: Psychological Assessment Resources.
American Academy of Pediatrics Healthy Children Org. (2016). How to develop a family media plan [Website]. https://www.healthychildren.org/English/family-life/Media/Pages/How-to-Make-a-Family-Media-Use-Plan.aspx
Beal JA Screen Time and Toddlers: New Evidence on Potentially Negative Effects. MCN Am J Matern Child Nurs. 2020 Jul/Aug;45(4):241. doi: 10.1097/NMC.0000000000000632. No abstract available.
Chia, M , Tay, L. Y., & Chua, T. B. K. (2019). The development of an online surveillance of digital media use in early childhood questionnaire-SMALLQ™-for Singapore.
Huang Y, Yan Q, Tong L Reliability and validity of an observation-based parent-child interaction rating scale for Chinese children aged 0-6 years. Psychol Assess. 2022 May;34(5):e45-e54. doi: 10.1037/pas0001121. Epub 2022 Mar 24.
Madigan S, Browne D, Racine N, Mori C, Tough S Association Between Screen Time and Children's Performance on a Developmental Screening Test. JAMA Pediatr. 2019 Mar 1;173(3):244-250. doi: 10.1001/jamapediatrics.2018.5056. Erratum In: JAMA Pediatr. 2019 May 1;173(5):501-502.
Radesky JS, Christakis DA Increased Screen Time: Implications for Early Childhood Development and Behavior. Pediatr Clin North Am. 2016 Oct;63(5):827-39. doi: 10.1016/j.pcl.2016.06.006.
Xie G, Deng Q, Cao J, Chang Q Digital screen time and its effect on preschoolers' behavior in China: results from a cross-sectional study. Ital J Pediatr. 2020 Jan 23;46(1):9. doi: 10.1186/s13052-020-0776-x.
The Relationship Between the Digital Media Usage With Impulsivity and Attention Deficit in Children With Early Intervention
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
